Skip to main content
Premium Trial:

Request an Annual Quote

Genentech to Use Horizon's X-MAN Line

NEW YORK (GenomeWeb News) – Roche subsidiary Genentech will use Horizon Discovery's mutant-and-normal cell lines in its oncology drug research programs under a three year agreement, Horizon said today.

The agreement, which expands an ongoing relationship between the companies, will give Genentech access to Horizon's X-MAN cell-line library.

Earlier in 2009, Genentech licensed the rights to use Horizon's GENESIS gene engineering platform to develop genetically defined human cancer models for drug studies.

The relationship between the two companies "has yielded some exciting findings which are being translated into publications that will help others striving to develop targeted cancer agents," Paul Morrill, business development director at Horizon, said in a statement.

Horizon said that Genentech has agreed to pay up-front, milestone and renewal fees, but it did not provide specific details of the financial terms.

The Scan

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.

Seagull Microbiome Altered by Microplastic Exposure

The overall diversity and the composition at gut microbiome sites appear to coincide with microplastic exposure and ingestion in two wild bird species, according to a new Nature Ecology and Evolution study.

Study Traces Bladder Cancer Risk Contributors in Organ Transplant Recipients

In eLife, genome and transcriptome sequencing reveal mutation signatures, recurrent somatic mutations, and risky virus sequences in bladder cancers occurring in transplant recipients.

Genes Linked to White-Tailed Jackrabbits' Winter Coat Color Change

Climate change, the researchers noted in Science, may lead to camouflage mismatch and increase predation of white-tailed jackrabbits.